[EN] IN VIVO ASSEMBLY OF ASGPR BINDING THERAPEUTICS<br/>[FR] ASSEMBLAGE IN VIVO D'AGENTS THÉRAPEUTIQUES DE LIAISON À ASGPR
申请人:AVILAR THERAPEUTICS INC
公开号:WO2022035997A1
公开(公告)日:2022-02-17
Compounds are provided that assemble together in vivo to form an ASGPR-binding compound that has an asialoglycoprotein receptor (ASGPR) binding ligand bound to an extracellular protein binding ligand for the selective degradation of the target extracellular protein in vivo to treat disorders mediated by the extracellular protein.